Percheron Therapeutics (ASX:PER)
ASX announcement history & article coverage
Transparent by design.
Announcments by Percheron Therapeutics (ASX:PER) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - PER
Completion of HMBD-002 Drug Substance Manufacture
New HMBD-002 Data Presented at ASCO Annual Meeting
Notification regarding unquoted securities - PER
Proposed issue of securities - PER
WHO selects proposed INN for HMBD-002
Notification of cessation of securities - PER
Quarterly Activities Report and Appendix 4C
Percheron raises $2.2M, advances HMBD-002 to phase II trial with key conference presentations and manufacturing underway
Notification regarding unquoted securities - PER
Application for quotation of securities - PER
New HMBD-002 Data Presented at AACR Annual Meeting
Update - Notification regarding unquoted securities - PER
Update - Notification regarding unquoted securities - PER
Notification regarding unquoted securities - PER
Notification regarding unquoted securities - PER
Change of Director's Interest Notice
Notification regarding unquoted securities - PER
Application for quotation of securities - PER
Results of Entitlement Offer
Percheron Therapeutics Raises $2.2M to Advance HMBD-002 Phase II Trial
